Red lines and green lights: Gene therapy for inherited erythroid disorders beyond the haemoglobinopathies. [PDF]
Gene therapy is revolutionizing treatment paradigms for haemoglobinopathies, establishing a translational framework for disorders that impact red blood cell development. In their paper, Joshi et al. describe the preclinical and early clinical landscape of gene therapies for non‐haemoglobinopathy erythroid disorders and highlight common thematic ...
Joshi G +3 more
europepmc +2 more sources
Erythrodontia in congenital erythropoietic porphyria. [PDF]
Congenital erythropoietic porphyria (CEP) is one of the rarest of porphyrias occurring worldwide. CEP is a very rare genetic autosomal recessive disease, with mutation in the gene that codifies uroporphyrinogen-III synthase, leading to porphyrin accumulation in many tissues, with marked skin photosensitivity, hemolytic anemia with splenomegaly and a ...
Bhavasar R, Santoshkumar G, Prakash BR.
europepmc +4 more sources
Neonatal hemolytic anemia does not always indicate thalassemia: a case report
Background Congenital erythropoietic porphyria is a rare autosomal recessive disorder that affects heme-porphyrin synthesis. This disorder is due to the genetic defect of uroporphyrinogen III cosynthase.
Arwa A. Al-Harazi +2 more
doaj +1 more source
Gunther’s Disease: Esthetic Management of Erythrodontia; 1-year Follow-up [PDF]
Intrinsic tooth stains are more permanent in nature than extrinsic stains and can be divided into two types systemic and local. Erythrodontia is reddish-brown or reddish-black discoloration of teeth caused due to congenital erythropoietic porphyria (CEP)
Pranjal Sharma +2 more
doaj +1 more source
Congenital erythropoietic porphyria: Recent advances. [PDF]
Congenital erythropoietic porphyria (CEP) is a rare autosomal recessive disorder characterized by photosensitivity and by hematologic abnormalities in affected individuals. CEP is caused by mutations in the uroporphyrinogen synthase (UROS) gene. In three reported cases, CEP has been associated with a specific X-linked GATA1 mutation.
Erwin AL, Desnick RJ.
europepmc +4 more sources
A simple Rx for congenital erythropoietic porphyria. [PDF]
Abkowitz JL.
europepmc +3 more sources
Letter to the Editor—Comment on “Erythropoietic Protoporphyria and Surgery: A Case of Successful Mastectomy With Perioperative Light Shielding Strategies Based on Light‐Induced Hemolytic Threshold Assessment” [PDF]
The Journal of Dermatology, Volume 53, Issue 9, Page e767-e768, September 2026.
de Rover I +3 more
europepmc +2 more sources
Transcription Factors GATA1/2 in Hematological Disorders. [PDF]
ABSTRACT Background GATA1 and GATA2 are zinc‐finger transcription factors essential for normal hematopoiesis. As genetic testing becomes more widely integrated into clinical practice, GATA1/2‐related disorders are increasingly recognized, making it important for clinicians to understand their diagnosis and management.
Karr M, Palmisiano N, Chen X.
europepmc +2 more sources
Clinically Important Features of Porphyrin and Heme Metabolism and the Porphyrias
Heme, like chlorophyll, is a primordial molecule and is one of the fundamental pigments of life. Disorders of normal heme synthesis may cause human diseases, including certain anemias (X-linked sideroblastic anemias) and porphyrias.
Siddesh Besur +3 more
doaj +1 more source
Advanced drug delivery systems targeting to improve therapeutic outcomes in porphyria
Porphyrias are known as disorders of the heme biosynthesis pathway. There are about eight metabolic disorders that make up the porphyrias. These eight metabolic disorders are porphyria cutanea tarda, acute intermittent porphyria, ALA-dehydratase ...
Dua, K +4 more
core +1 more source

